CO5590914A2 - Derivados de 5-(piridin-3-il)-1-azabiciclo [3.2.1] octano - Google Patents
Derivados de 5-(piridin-3-il)-1-azabiciclo [3.2.1] octanoInfo
- Publication number
- CO5590914A2 CO5590914A2 CO04062934A CO04062934A CO5590914A2 CO 5590914 A2 CO5590914 A2 CO 5590914A2 CO 04062934 A CO04062934 A CO 04062934A CO 04062934 A CO04062934 A CO 04062934A CO 5590914 A2 CO5590914 A2 CO 5590914A2
- Authority
- CO
- Colombia
- Prior art keywords
- groups
- group
- azepin
- trifluoromethoxy
- dialkylamino
- Prior art date
Links
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 title 1
- -1 nitro, amino Chemical group 0.000 abstract 7
- 125000005843 halogen group Chemical group 0.000 abstract 3
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
- 125000006310 cycloalkyl amino group Chemical group 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000004566 azetidin-1-yl group Chemical group N1(CCC1)* 0.000 abstract 1
- 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 abstract 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 abstract 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 abstract 1
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 1
- 125000004987 dibenzofuryl group Chemical group C1(=CC=CC=2OC3=C(C21)C=CC=C3)* 0.000 abstract 1
- 125000004988 dibenzothienyl group Chemical group C1(=CC=CC=2SC3=C(C21)C=CC=C3)* 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 125000001041 indolyl group Chemical group 0.000 abstract 1
- 125000000842 isoxazolyl group Chemical group 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000001644 phenoxazinyl group Chemical group C1(=CC=CC=2OC3=CC=CC=C3NC12)* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000003386 piperidinyl group Chemical group 0.000 abstract 1
- 125000003373 pyrazinyl group Chemical group 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000000714 pyrimidinyl group Chemical group 0.000 abstract 1
- 125000000168 pyrrolyl group Chemical group 0.000 abstract 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
1.- Compuesto, en forma de enantiómero puro o en forma de rnezcla de enantiómeros, que responde a la fórmula general ( I ): en la cual R representa un átomo de halógeno o un grupo cicloalquilo(C3-C6) o un grupo fenilo substituido por uno o varios grupos elegidos entre un átomo de halógeno, o un grupo alquilo (C1-C6), alcoxi (C1-C6), nitro, amino, dialquilamino (C1-C3), trifluorometilo, trifluorometoxi, ciano, hidroxi, acetilo o metilendioxi, o un grupo piperidinilo, o morfolin-4-ilo, o pirrolidin-1-ilo, o azetidin-1-ilo, o azepin-1-ilo, o azepin-1-ilo, o piridinilo, o quinolinilo, o tienilo, o pirazinilo, o furilo, o benzofurilo, o benzotienilo, o indolilo, o pirimidinilo o isoxazolilo, o fenoxazinilo, o fenoxatiinilo, o dibenzotienilo, o dibenzofurilo, o pirrolilo o naftilo, y cada uno de esos grupos puede eventualmente ser substituido por uno o varios grupos elegidos entre los átomos de halógenos, los grupos alquilo (C1-C6), alcoxi (C1-C6), trifluorometoxi, trifluorometilo, nitro, ciano, hidroxi, amino, dialquilamino (C1-C3) o cicloalquilamino (C1-C8), y se sabe que entre los dos enlaces carbono-carbono representados por - - -, uno es simple y el otro puede ser simple o doble,en estado de base o de sal derivada de adición con un ácido.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0200109A FR2834511B1 (fr) | 2002-01-07 | 2002-01-07 | Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5590914A2 true CO5590914A2 (es) | 2005-12-30 |
Family
ID=8871176
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO04062934A CO5590914A2 (es) | 2002-01-07 | 2004-07-01 | Derivados de 5-(piridin-3-il)-1-azabiciclo [3.2.1] octano |
Country Status (35)
| Country | Link |
|---|---|
| US (2) | US7223750B2 (es) |
| EP (1) | EP1465893B1 (es) |
| JP (1) | JP4402957B2 (es) |
| KR (1) | KR100977332B1 (es) |
| CN (2) | CN1911928A (es) |
| AR (2) | AR038098A1 (es) |
| AT (1) | ATE355290T1 (es) |
| AU (1) | AU2003216777B2 (es) |
| BR (1) | BR0306707A (es) |
| CA (1) | CA2471628C (es) |
| CO (1) | CO5590914A2 (es) |
| CY (1) | CY1106580T1 (es) |
| DE (1) | DE60312123T2 (es) |
| DK (1) | DK1465893T3 (es) |
| EA (1) | EA007793B1 (es) |
| EC (1) | ECSP045176A (es) |
| ES (1) | ES2281631T3 (es) |
| FR (1) | FR2834511B1 (es) |
| HR (1) | HRP20040617B1 (es) |
| IL (2) | IL162524A0 (es) |
| IS (1) | IS2470B (es) |
| MA (1) | MA27165A1 (es) |
| ME (2) | MEP24408A (es) |
| MX (1) | MXPA04006630A (es) |
| NO (1) | NO329309B1 (es) |
| NZ (1) | NZ533793A (es) |
| PL (1) | PL216665B1 (es) |
| PT (1) | PT1465893E (es) |
| RS (1) | RS50921B (es) |
| SI (1) | SI1465893T1 (es) |
| TN (1) | TNSN04120A1 (es) |
| TW (1) | TWI336703B (es) |
| UA (1) | UA77229C2 (es) |
| WO (1) | WO2003057697A1 (es) |
| ZA (1) | ZA200405002B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9902007D0 (en) * | 1999-01-30 | 1999-03-17 | Thomas Carpentry Services Limi | Improvements relating to door frames |
| FR2834511B1 (fr) * | 2002-01-07 | 2004-02-13 | Sanofi Synthelabo | Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique |
| FR2889701B1 (fr) * | 2005-08-12 | 2007-10-05 | Sanofi Aventis Sa | Derives de 5-pyridinyl-1-azabicyclo[3.2.1]octane, leur preparation en therapeutique. |
| FR2889847B1 (fr) * | 2005-08-18 | 2007-10-05 | Sanofi Aventis Sa | Derives de 5-pyridazinyl-1-azabicyclo[3.2.1]octave, leur preparation en therapeutique. |
| FR2912404B1 (fr) * | 2007-02-09 | 2009-04-10 | Sanofi Aventis Sa | Derives d'azabicycloalkane,leur preparation et leur application en therapeutique. |
| KR101925971B1 (ko) | 2011-01-28 | 2018-12-06 | 에스케이바이오팜 주식회사 | 피리돈 유도체 및 이를 포함하는 약학적 조성물 |
| KR101928505B1 (ko) | 2011-01-28 | 2018-12-12 | 에스케이바이오팜 주식회사 | 피리돈 유도체 및 이를 포함하는 약학적 조성물 |
| KR20200083976A (ko) | 2017-11-03 | 2020-07-09 | 알콘 인코포레이티드 | 눈 장애의 치료를 위한 아자바이시클로 및 디아제핀 유도체 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5817679A (en) * | 1993-04-01 | 1998-10-06 | University Of Virginia | 7-Azabicyclo 2.2.1!-heptane and -heptene derivatives as cholinergic receptor ligands |
| AU7474794A (en) | 1993-07-22 | 1995-02-20 | E.I. Du Pont De Nemours And Company | Arthropodicidal azacyclic heterocycles |
| FR2786769B1 (fr) * | 1998-12-04 | 2002-10-25 | Synthelabo | Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique |
| FR2786770B1 (fr) * | 1998-12-04 | 2001-01-19 | Synthelabo | Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique |
| FR2834511B1 (fr) * | 2002-01-07 | 2004-02-13 | Sanofi Synthelabo | Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique |
-
2002
- 2002-01-07 FR FR0200109A patent/FR2834511B1/fr not_active Expired - Fee Related
- 2002-12-31 TW TW091138055A patent/TWI336703B/zh not_active IP Right Cessation
-
2003
- 2003-01-03 NZ NZ533793A patent/NZ533793A/en not_active IP Right Cessation
- 2003-01-03 HR HRP20040617AA patent/HRP20040617B1/hr not_active IP Right Cessation
- 2003-01-03 ES ES03712202T patent/ES2281631T3/es not_active Expired - Lifetime
- 2003-01-03 EA EA200400770A patent/EA007793B1/ru not_active IP Right Cessation
- 2003-01-03 CA CA2471628A patent/CA2471628C/en not_active Expired - Fee Related
- 2003-01-03 MX MXPA04006630A patent/MXPA04006630A/es active IP Right Grant
- 2003-01-03 DE DE60312123T patent/DE60312123T2/de not_active Expired - Lifetime
- 2003-01-03 KR KR1020047010566A patent/KR100977332B1/ko not_active Expired - Fee Related
- 2003-01-03 AU AU2003216777A patent/AU2003216777B2/en not_active Ceased
- 2003-01-03 ME MEP-244/08A patent/MEP24408A/xx unknown
- 2003-01-03 AT AT03712202T patent/ATE355290T1/de active
- 2003-01-03 ME MEP-2008-244A patent/ME00213B/me unknown
- 2003-01-03 IL IL16252403A patent/IL162524A0/xx unknown
- 2003-01-03 US US10/500,015 patent/US7223750B2/en not_active Expired - Lifetime
- 2003-01-03 CN CNA2006101091747A patent/CN1911928A/zh active Pending
- 2003-01-03 AR ARP030100009A patent/AR038098A1/es not_active Application Discontinuation
- 2003-01-03 SI SI200330774T patent/SI1465893T1/sl unknown
- 2003-01-03 EP EP03712202A patent/EP1465893B1/fr not_active Expired - Lifetime
- 2003-01-03 DK DK03712202T patent/DK1465893T3/da active
- 2003-01-03 PT PT03712202T patent/PT1465893E/pt unknown
- 2003-01-03 PL PL370065A patent/PL216665B1/pl unknown
- 2003-01-03 JP JP2003558012A patent/JP4402957B2/ja not_active Expired - Fee Related
- 2003-01-03 WO PCT/FR2003/000004 patent/WO2003057697A1/fr not_active Ceased
- 2003-01-03 BR BR0306707-6A patent/BR0306707A/pt not_active Application Discontinuation
- 2003-01-03 CN CNB038019876A patent/CN1276921C/zh not_active Expired - Fee Related
- 2003-01-03 RS YUP-599/04A patent/RS50921B/sr unknown
- 2003-03-01 UA UA20040605056A patent/UA77229C2/uk unknown
-
2004
- 2004-06-14 IL IL162524A patent/IL162524A/en not_active IP Right Cessation
- 2004-06-16 IS IS7322A patent/IS2470B/is unknown
- 2004-06-24 ZA ZA200405002A patent/ZA200405002B/en unknown
- 2004-06-29 EC EC2004005176A patent/ECSP045176A/es unknown
- 2004-06-30 TN TNP2004000120A patent/TNSN04120A1/fr unknown
- 2004-07-01 MA MA27759A patent/MA27165A1/fr unknown
- 2004-07-01 CO CO04062934A patent/CO5590914A2/es active IP Right Grant
- 2004-07-05 NO NO20042846A patent/NO329309B1/no not_active IP Right Cessation
-
2007
- 2007-04-05 US US11/696,993 patent/US7585974B2/en not_active Expired - Fee Related
- 2007-05-10 CY CY20071100641T patent/CY1106580T1/el unknown
-
2012
- 2012-05-28 AR ARP120101864A patent/AR086573A2/es not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2183548T3 (es) | Dihidropirimidinas. | |
| AR037402A1 (es) | Derivados de 4-(oxadiazol-3-il)-1,4-diazabiciclo[3.2.2]nonano, su preparacion y su aplicacion en terapeutica | |
| ES2524119T3 (es) | Furazanobencimidazoles como profármacos para tratar enfermedades neoplásicas o autoinmunes | |
| AR034405A1 (es) | Composiciones farmaceuticas que contienen derivados de 3-amino-azetidina, los nuevos derivados y su preparacion | |
| ES2181413T3 (es) | Nuevas dihidropiridinas sustituidas en 2 con heterociclo. | |
| EA200600509A1 (ru) | Соединения пиримидотиофена | |
| DE602004008098D1 (de) | Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren | |
| AR062640A1 (es) | Compuestos de azolcarboxamidas y composiciones herbicidas | |
| CO4820390A1 (es) | Quinazolinas substituidas y bioisoesteres como inhibidores de la tirosina cinasa c-erb b- 2 | |
| ATE260275T1 (de) | Substituierte thien-3-yl- sulfonylamino(thio)carbonyl-triazolin(thi)one | |
| ES2184280T3 (es) | Compuestos de indol como inhibidores de cox-2'. | |
| EA200600594A1 (ru) | Новые гетероциклические соединения - ингибиторы hsp90 и способы их получения | |
| ES2192520T3 (es) | Composicion farmaceutica. | |
| DK0931788T3 (da) | Metalloproteasehæmmere | |
| BRPI0615111B8 (pt) | composto, composição farmacêutica, e, uso do composto | |
| CO5700820A2 (es) | Derivados de dioxan-2-alquilcarbamatos, su preparacion y su aplicacion en terapeutica | |
| AR037403A1 (es) | Compuestos, ligandos, receptores nicotinicos, utiles para el tratamiento o para la prevencion de desordenes relacionados con una disfuncion de receptores nicotinicos, particularmente a nivel del sistema nervioso central | |
| ECSP066695A (es) | Derivados de n-(1,5-difenil-1h-pirazol-3-il) sulfonamida con afinidad por los receptores cb1 | |
| PE20011115A1 (es) | Etanos tri-aril-sustituidos inhibidores de pde4 | |
| CO5590914A2 (es) | Derivados de 5-(piridin-3-il)-1-azabiciclo [3.2.1] octano | |
| PE20001083A1 (es) | Derivados de mononitrato de isosorbide | |
| ES2182546T3 (es) | Imidazo(1,2a)azinas sustituidas como inhibidores selectivos de la cox-2. | |
| AR038276A1 (es) | Metodos para incrementar la formacion osea. | |
| ES2177275T3 (es) | Derivados de oxadiazolina y su uso como insecticidas. | |
| ES2190252T3 (es) | Derivados de 2-fenilpiran-4-ona. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Application granted |